Live
IlluminaAssenagon Asset Management S.A. Trims Holdings in Illumina, Inc. $ILMN - MarketBeatThermo FisherDoes Thermo Fisher’s New SHL Autoinjector Hub Reshape Its Device Integration Strategy For TMO? - simplywall.stIlluminaIllumina outperforms Complete Genomics/MGI in a head-to-head whole-genome sequencing (WGS) comparison - IlluminaeLifeThe self-interest of adolescents overrules cooperation in social dilemmas10x Genomics BlogWilliam Blair upgrades 10X Genomics stock rating on AI drug discovery role - Investing.comThermo FisherThermo Fisher Scientific Inc. stock rises Monday, outperforms market - MarketWatchBioPharma DiveBlackstone closes $6.3B fund for life sciences investingFierceBiotechBlackstone closes record $6.3B life sciences fundFierceBiotechAstellas axes early Sjögren’s trial in latest setback for autoimmune disease communityFierceBiotechJohnson & Johnson’s Impella pumps miss the mark in 2 major coronary studiesBioPharma DiveUnited rises on IPF data; Biogen scores positive lupus data and an approvalEndpoints News#ACC26: Merck touts comparator data for oral cholesterol drug
Illumina Mar 31, 2026

Assenagon Asset Management S.A. Trims Holdings in Illumina, Inc. $ILMN - MarketBeat

Assenagon Asset Management S.A. Trims Holdings in Illumina, Inc. $ILMN - MarketBeat

Original
Body unavailable. Use the original source.

Directory

59 All